ALX Oncology Reports Q2 2026 Financial Results

What Happened

• ALX Oncology Holdings, Inc. announced its financial results for the quarter ended June 30, 2026, in a press release dated August 6, 2026. The company filed a Current Report on Form 8‑K (Item 2.02) to furnish that press release, which is included as Exhibit 99.1 and incorporated by reference.

Key Details

• Date of filing and press release: August 6, 2026.
• Reporting period: second quarter ended June 30, 2026.
• Exhibit furnished: Press Release (Exhibit 99.1) was attached to the 8‑K.
• Report signed on behalf of the company by Harish Shantharam, Chief Financial Officer.

Why It Matters

• This 8‑K notifies investors that ALX has released its latest quarterly earnings and financial condition information; investors should review the attached press release for revenue, net income/loss, cash position, and any operational updates.
• Filing the press release on Form 8‑K makes the information official and available to the market in a machine‑readable format (Inline XBRL is included with the filing), which can affect trading and investor decisions once the detailed figures and commentary are reviewed.